Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The daily Top 10 COVID papers

Head and Neck Cancer

Free Subscription 23.11.2020 2 Ann Otol Rhinol Laryngol 5 Ann Surg 2 Ann Thorac Surg 1 BMC Cancer 1 BMC Surg 1 Cancer Res 2 Gastrointest Endosc 1 Head Neck 1 HNO 1 J Oral Maxillofac Surg 1 Laryngoscope 7 Oral Oncol 1 PLoS One 2 Radiother Oncol 1 Surgery 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Otol Rhinol Laryngol

1. CASS ND, Schopper MA, Lubin JA, Fishbein L, et al
   The Changing Paradigm of Head and Neck Paragangliomas: What Every Otolaryngologist Needs to Know.
   Ann Otol Rhinol Laryngol. 2020;129:1135-1143.
   PubMed         Abstract available
   
   
2. AL-QURAYSHI Z, Smith R, Walsh JE
   Sinonasal Squamous Cell Carcinoma Presentation and Outcome: A National Perspective.
   Ann Otol Rhinol Laryngol. 2020;129:1049-1055.
   PubMed         Abstract available
   
   

   
   Ann Surg

3. XUE FS, Xue ZJ, Wan L
   Comment on "Acute Kidney Injury After Esophageal Cancer Surgery: Incidence, Risk Factors, and Impact on Oncologic Outcomes".
   Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004614.
   PubMed        
   
   
4. MURPHY CF, Dunne T, Elliott JA, Kamarajah SK, et al
   Response to "Comment on Acute Kidney Injury after Esophageal Cancer Surgery: Incidence, Risk Factors, and Impact on Oncologic Outcomes".
   Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004609.
   PubMed        
   
   
5. MAKINO T, Hagi T, Doki Y
   Response to Comment on: "Pathological Regression of Lymph Nodes Better Predicts Long-Term Survival in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery".
   Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004605.
   PubMed        
   
   
6. CHEN D, Wen J, Zheng Y, Chen Y, et al
   Comment on "Pathological Regression of Lymph Nodes Better Predicts Long-term Survival in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery".
   Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004606.
   PubMed        
   
   
7. RAFTERY NB, Murphy CF, Donohoe CL, O'Connell B, et al
   The Complexity of Defining Postoperative Pneumonia following Esophageal Cancer Surgery: A Spectrum of Lung Injury rather than a simple Infective complication?
   Ann Surg. 2020 Nov 12. doi: 10.1097/SLA.0000000000004546.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

8. YE C, Guo J, Liu X, Jiang G, et al
   Surgery and Proton Beam Therapy for Tracheal Synovial Sarcoma.
   Ann Thorac Surg. 2020;110:e265-e267.
   PubMed         Abstract available
   
   
9. WANG W, Sang Y, Chen Y
   Should Neoadjuvant Therapy be a Standard Modality for Patients with Clinical T2N0 Esophageal Cancer?
   Ann Thorac Surg. 2020 Nov 16. pii: S0003-4975(20)31916.
   PubMed        
   
   

   
   BMC Cancer

10. KAGAMI T, Yamade M, Suzuki T, Uotani T, et al
    The first evidence for SLFN11 expression as an independent prognostic factor for patients with esophageal cancer after chemoradiotherapy.
    BMC Cancer. 2020;20:1123.
    PubMed         Abstract available
    
    

    
    BMC Surg

11. HU J, Lu D, Ren J, Wen Q, et al
    Adult laryngeal Embryonal Rhabdomyosarcoma: a case report and literature review.
    BMC Surg. 2020;20:173.
    PubMed         Abstract available
    
    

    
    Cancer Res

12. ABBASSI-GHADI N, Antonowicz SS, McKenzie JS, Kumar S, et al
    De Novo Lipogenesis Alters the Phospholipidome of Esophageal Adenocarcinoma.
    Cancer Res. 2020;80:2764-2774.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

13. DU C, Chai N, Linghu E, Tang X, et al
    Spraying vitamin C solution for relief of mucosal irritation caused by Lugol chromoendoscopy.
    Gastrointest Endosc. 2020;91:1409-1410.
    PubMed        
    
    
14. PERBTANI Y, Qumseya BJ
    A prediction model for detection of esophageal squamous cell cancer: A new beginning or more of the same?
    Gastrointest Endosc. 2020;91:1261-1263.
    PubMed        
    
    

    
    Head Neck

15. AKALI NR, Buggaveeti R, Sukumaran SV, Balasubramanian D, et al
    Prior chemoradiotherapy and pathological perineural invasion predict the survival outcomes of salvage surgery in head and neck squamous cell carcinoma.
    Head Neck. 2020 Nov 21. doi: 10.1002/hed.26547.
    PubMed         Abstract available
    
    

    
    HNO

16. TACHE P, Henschke F, Folz BJ
    [Recurrent epistaxis in the presence of a nasopharyngeal mass].
    HNO. 2020;68:869-871.
    PubMed        
    
    

    
    J Oral Maxillofac Surg

17. YAMAGATA K, Fukuzawa S, Uchida F, Ishibashi-Kanno N, et al
    Is Preoperative Plate-Lymphocyte Ratio a Predictor of Deep Vein Thrombosis in Patients With Oral Cancer During Surgery?
    J Oral Maxillofac Surg. 2020 Oct 17. pii: S0278-2391(20)31302.
    PubMed         Abstract available
    
    

    
    Laryngoscope

18. CHAKRABARTI S, Gupta DK
    Response to Letter to Editor for Islanded Pedicled Nasolabial Flap.
    Laryngoscope. 2020;130:E501.
    PubMed        
    
    

    
    Oral Oncol

19. LIU AK, Wu J, Berthelet E, Lalani N, et al
    Clinical features of head and neck cancer patients with brain metastases: A retrospective study of 88 cases.
    Oral Oncol. 2020;112:105086.
    PubMed         Abstract available
    
    
20. REGO-LORCA D, Burgos-Blasco B, Hernandez-Garcia E, Domingo-Gordo B, et al
    Abducens palsy as first manifestation of a nasopharyngeal carcinoma.
    Oral Oncol. 2020 Nov 10:105079. doi: 10.1016/j.oraloncology.2020.105079.
    PubMed        
    
    
21. ZHAI TT, Wesseling F, Langendijk JA, Shi Z, et al
    External validation of nodal failure prediction models including radiomics in head and neck cancer.
    Oral Oncol. 2020;112:105083.
    PubMed         Abstract available
    
    
22. HANNA GJ, Rettig EM, Park JC, Varvares MA, et al
    Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19.
    Oral Oncol. 2020;112:105087.
    PubMed         Abstract available
    
    
23. WIJETUNGA NA, Yu Y, Morris LG, Lee N, et al
    The head and neck cancer genome in the era of immunotherapy.
    Oral Oncol. 2020;112:105040.
    PubMed         Abstract available
    
    
24. CHAKRABARTI D, Akhtar N, Qayoom S, Rajan S, et al
    Optimising elective neck dissection for early oral cancers.
    Oral Oncol. 2020 Nov 13:105090. doi: 10.1016/j.oraloncology.2020.105090.
    PubMed        
    
    
25. ZHAO XT, Zhu Y, Zhou JF, Gao YJ, et al
    Development of a novel 7 immune-related genes prognostic model for oral cancer: A study based on TCGA database.
    Oral Oncol. 2020;112:105088.
    PubMed         Abstract available
    
    

    
    PLoS One

26. BJERKLI IH, Laurvik H, Nginamau ES, Soland TM, et al
    Tumor budding score predicts lymph node status in oral tongue squamous cell carcinoma and should be included in the pathology report.
    PLoS One. 2020;15:e0239783.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

27. LIANG SB, Chen LS, Yang XL, Chen DM, et al
    Influence of Tumor Necrosis on Treatment Sensitivity and Long-term Survival in Nasopharyngeal Carcinoma.
    Radiother Oncol. 2020 Nov 17. pii: S0167-8140(20)31165.
    PubMed         Abstract available
    
    
28. HIROSE K, Konno A, Hiratsuka J, Yoshimoto S, et al
    Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan((10)B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial.
    Radiother Oncol. 2020 Nov 10. pii: S0167-8140(20)30890.
    PubMed         Abstract available
    
    

    
    Surgery

29. KULSHRESTHA S, Bunn C, Patel PM, Sweigert PJ, et al
    Textbook oncologic outcome is associated with increased overall survival after esophagectomy.
    Surgery. 2020;168:953-961.
    PubMed         Abstract available
    
    

    
    Thyroid

30. TAIEB D, Castinetti F
    PET imaging in medullary thyroid carcinoma: time for reappraisal?
    Thyroid. 2020 Nov 15. doi: 10.1089/thy.2020.0674.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: